Need about tumor treatment!Hefei this clinical trial has key progress!

Author:Hefei Daily Time:2022.08.10

On the morning of August 10th, the last proton clinical trial patients in Hefei ion Medical Center completed the treatment and discharged, which means that the first domestic introduction with 360 ° rotation rack Probeam proton therapy system was successfully completed the clinical trial treatment stage, and registered registration to complete the registration The last step of formal entering clinical operations takes a key last step, and also reserves practical experience for the first -phase domestic first -stage domestic superconducting back -to -rotor equipment.

"A total of 35 proton ray treatment was received, basically there was no discomfort." At 10 am, the 47th in the morning, the last case of the last subject completed the last treatment, stepped out of the Hefei ion Medical Center No. 5, No. 5, No. 5 Treatment room.

Proton therapy is the most cutting -edge high -end radiotherapy method today, which can accurately "fixed -point blasting and clearing" on tumor lesions. This clinical trial officially started on December 30, 2021. The scope of the group included head and neck tumors, nervous system tumors, chest tumors, abdominal tumors, pelvic tumors, etc., with a wide range of coverage.

"From the current treatment situation, compared with traditional radiotherapy, the treatment effect is better than the normal tissue, and the normally tissue and side effects have significantly improved the quality of survival of patients with tumor patients." ) Chief expert Zhang Hongyan said that in the next step, we will continue to follow up with these 47 patients in accordance with the clinical trial plan, mainly to observe the long -term effects and side effects of the treatment.

According to reports, the treatment cycle of clinical trial research is 1-8 weeks, short-term follow-up after treatment of about 3 months, and long-term follow-up for 5 years. As of now, 17 patients have completed a short -term efficiency assessment, and the effective rate of local tumor control has reached 100%. There is no case of virus and side reactions above level III and III or above. In the later period, the medical team will continue to follow the observation of follow -up effects and long -term side effects.

According to the staff, after completing all the patients in the three -month short -term follow -up, all test data will be sorted out, and the registration application for proton equipment will be submitted to the State Drug Administration in order to obtain the approval of the State Drug Administration as soon as possible to formally put the proton therapy into the clinical clinical Operation allows tumor patients to use the most advanced radiotherapy technology at an early date to benefit the majority of tumor patients.

Proton radiotherapy equipment at Hefei ion Medical Center. (Data map)

News link:

The Hefei ion Medical Center project is wholly -owned by Hefei City's financial funds, officially launched in October 2015, construction was started in June 2017. In July 2021, the "proton radiation therapy system permit" was obtained by the National Health and Health Commission. 11 The "radiation safety permit" issued by the Ministry of Ecological and Environmental Protection of the National Ecological and Environment Month, officially started clinical trials on December 30, 2021, and completed the treatment of all clinical trial patients on August 10, 2022.

Hefei ion Medical Center. (Data Questions) Photo by Song Yanjun, a reporter of all media


Text, Photography | All Media Reporter Ge Qingzheng

Editing | All Media Editor Cheng Xiaodan

Edit | All media editors Zhou Qiao

Produced | "Combined Power" Rong Media Studio, "Lakeside Point" Rong Media Studio

- END -

Is it okay to drive a red light under the shadow?Practical sunscreen is here!

Breaking through the high temperature of 30 ° C, it is announced that the summer ...

Convenient service zero -run legs Rizhao Medical Insurance "hand -in -hand office" and "online handling"

Luwang, July 22, Mr. Zhao, a citizen, is a company staff who needs to be transferr...